Consensus statement on the use of clozapine during the COVID-19 pandemic
Dan Siskind, William G. Honer, Scott R. Clark, Christoph U. Correll, Alkomiet Hasan, Oliver Howes, John M. Kane, Deanna L. Kelly, Robert S. Laitman, Jimmy Lee, James H. MacCabe, Nick Myles, Jimmi Nielsen, Peter F.J. Schulte, David Taylor, Hélène Verdoux, Amanda Wheeler, Oliver Freudenreich
Abstract
With the ongoing coronavirus disease 2019 (COVID-19) pandemic, psychiatrists find themselves in the clinical situation of being asked by patients, family members and patient advocacy societies to help ensure access to clozapine as a medication critical for ongoing patient care. To provide clozapine
Topics & Concepts
ClozapinePandemicCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakStatement (logic)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusMedicinePsychiatryPsychologyIntensive care medicineDiseasePolitical scienceVirologyInfectious disease (medical specialty)Schizophrenia (object-oriented programming)LawInternal medicineOutbreakSchizophrenia research and treatmentMental Health Treatment and AccessPsychiatric care and mental health services